Back to search

United Kingdom· GB-APID-4446711000001108

Zerit 40mg capsules

A stavudine product containing stavudine, registered in United Kingdom by Bristol-Myers Squibb Pharmaceuticals Ltd. The same ATC class is registered in 3 of our 19 countries.

ATC J05AF04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedZerit 40mg capsulesATCJ05AF04REGISTER NO.GB-APID-4446711000001…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Stavudine is registered in 3 of 19 countries.

Countries holding a registration under ATC J05AF04 (stavudine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 2 of them publish a price we can compare per daily dose

Stavudine · ATC J05AF04

3 / 19 countries

  • Belgiumprice
  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Stavudine
Manufacturer
Bristol-Myers Squibb Pharmaceuticals Ltd
Country
United Kingdom (GB)
ATC code
J05AF04
ATC class
Stavudine
Defined daily dose
80 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5012712002116

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

176 interactions on record for stavudine.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Stavudine · interactions on record

176 records

  • 6 severe
  • 83 moderate
  • 87 info

Most severe, free to view

  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • LeflunomidL04AA13severe
  • TeriflunomidL04AA31severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Stavudine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All stavudine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e06acd9b-4e22-466d-b9b6-5843549bf075
GET /v1/drugs/e06acd9b-4e22-466d-b9b6-5843549bf075?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4446711000001108",
  "desc": "Zerit 40mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)",
  "form": "Oral capsule",
  "vpid": "41770111000001109",
  "source": "dmd",
  "vtm_id": "777609003",
  "strength": "40 mg",
  "substance": "Stavudine",
  "ingredient": "Stavudine",
  "supplier_code": "3145301000001104"
}

See everything about stavudine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.